Proactively Identify FDA Inspection Risks with AI

FDA inspections do not create compliance failures. They surface ones that already existed. AI regulatory intelligence replaces point-in-time mock audits with continuous gap detection across 150+ frameworks — FDA 21 CFR, EU GMP, and ICH — from preclinical through post-market surveillance. Here's how the four-pillar platform closes the loop before inspectors arrive.